Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
International Journal of Integrated Care|March 5, 2021
Reorganizing the Multidisciplinary Team Meetings in a Tertiary Centre for Gastro-Intestinal Oncology Adds Value to the Internal and Regional Care Pathways. A Mixed Method EvaluationLidia S van Huizen, Pieter U Dijkstra, Patrick H J Hemmer, et al.Cancers|January 11, 2022
Outcomes after Surgical Treatment of Metastatic Disease in the Adrenal Gland; Valuable for the Patient?Madelon J H Metman, Charlotte L Viëtor, Auke J Seinen, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2019
Delta peritoneal cancer index (ΔPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastasesJudith E K R Hentzen, Willemijn Y van der Plas, Hendrien Kuipers, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2021
Clinical selection strategy for and evaluation of intra-operative brachytherapy in patients with locally advanced and recurrent rectal cancerEsmée A Dijkstra, Véronique E M Mul, Patrick H J Hemmer, et al.Annals of Surgical Oncology|March 17, 2019
Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational StudyJudith E K R Hentzen, Koen P Rovers, Hendrien Kuipers, et al.BJS Open|October 11, 2022
Impact of cumulative complications on 1-year treatment-related healthcare costs in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapyFemke A van der Zant, Bob J L Kooijman, Judith E K R Hentzen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2019
Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal CancerSteven J de Jongh, Jolien J J Tjalma, Marjory Koller, et al.JAMA Oncology|July 17, 2020
Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal MetastasesKoen P Rovers, Checca Bakkers, Felice N van Erning, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 7, 2024
Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapyMichelle V Dietz, Gerjon Hannink, Ibrahim Said, et al.Annals of Surgical Oncology|March 7, 2024
Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based StudyRoos G F M van der Ven, Teun B M van den Heuvel, Koen P B Rovers, et al.Pageof 3